Results
1 -
4 of
4
(Click
here to explore results)
- Targeting mechanism for SARS-CoV-2 in silico: interaction and key groups of TMPRSS2 toward four potential drugs. Xiaoyu Zhao, Song Luo, Kaifang Huang, Danyang Xiong, John Z. H. Zhang, Lili Duan
, Nanoscale
, 2021
, 13
, 19218
- Repurposing drugs against the main protease of SARS-CoV-2: mechanism-based insights supported by available laboratory and clinical data. Sohini Chakraborti, Sneha Bheemireddy, Narayanaswamy Srinivasan
, Mol. Omics
, 2020
, 16
, 474
- para-Sulphonato-calix[n]arene capped silver nanoparticles challenge the catalytic efficiency and the stability of a novel human gut serine protease inhibitor. Nizar Akermi, Hela Mkaouar, Aicha Kriaa, Amin Jablaoui, Souha Soussou, Ali Gargouri, Anthony W. Coleman, Florent Perret, Emmanuelle Maguin, Moez Rhimi
, Chem. Commun.
, 2019
, 55
, 8935
- Trends in protease inhibition. G. Fischer
, Nat. Prod. Rep.
, 1988
, 5
, 465